clinicaltrialvanguardOpinion

The EMA Just Opened a Door That Animal Testing Has Kept Closed for Decades

EMA's September 2026 NAM data pilot lets sponsors share organ-chip and computational data directly with regulators, reshaping ...
clinicaltrialvanguard

Your SAE Workflow Has a Dual-Entry Problem. Veeva’s Interoperability Move Just Made It Harder to Ignore.

Veeva Falcon Safety's E2B(R3) interoperability across all input channels signals the end of dual-entry SAE workflows—here's ...
clinicaltrialvanguard

PMV Pharma’s Rezatapopt Achieves 44% Response Rate in TP53 Y220C Ovarian Cancer

PMV Pharma's rezatapopt achieves 44% response rate in TP53 Y220C ovarian cancer patients, positioning the drug for potential ...
clinicaltrialvanguard

Girl with Griscelli Syndrome Type II undergoes first haploidentical transplant at Miami hospital

Girl with Griscelli Syndrome Type II receives first haploidentical transplant at Miami hospital, offering new hope for ...
clinicaltrialvanguard

Elevar Presents Age-Stratified Camrelizumab-Rivoceranib Data After FDA Rejection

Elevar presents age-stratified camrelizumab-rivoceranib data from Phase 3 CARES-310 after two FDA rejections, signaling ...